Cite

HARVARD Citation

    Lissitchkov, T. et al. (n.d.). Head‐to‐head comparison of the pharmacokinetic profiles of a high‐purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B. Haemophilia. pp. 674-678. [Online].

Back to record